Podchaser Logo
Home
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Released Friday, 28th October 2022
Good episode? Give it some love!
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial

Friday, 28th October 2022
Good episode? Give it some love!
Rate Episode

Host: Pavani Chalasani, MD, MPH

Guest: Hope S. Rugo, MD, FASCO

Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features